NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Open An Account
Partner Us
Downloads
Careers
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Financial Ratios
Financial Ratios
AUROBINDO PHARMA LTD.
NSE :
AUROPHARMA
BSE :
524804
ISIN CODE :
INE406A01037
Industry :
Pharmaceuticals & Drugs
House :
Aurobindo
BSE
927.95
-1.95 (-0.21 %)
PREV CLOSE (
)
929.90
OPEN PRICE (
)
930.15
BID PRICE (QTY)
927.70 (66)
OFFER PRICE (QTY)
928.10 (74)
VOLUME
16598
TODAY'S LOW / HIGH (
)
924.45
937.95
52 WK LOW / HIGH (
)
281.15
996.65
NSE
927.70
-2.3 (-0.25 %)
PREV CLOSE(
)
930.00
OPEN PRICE (
)
935.00
BID PRICE (QTY)
927.70 (15)
OFFER PRICE (QTY)
928.00 (10)
VOLUME
782115
TODAY'S LOW / HIGH(
)
924.40
938.00
52 WK LOW / HIGH (
)
288.85
996.85
Consolidated
Standalone
Select year
Mar2020
Mar2019
Mar2018
Mar2017
Mar2016
Particulars
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Operational & Financial Ratios
Earnings Per Share (Rs)
48.32
40.36
41.36
39.28
34.61
CEPS(Rs)
65.05
51.71
50.82
46.49
41.26
DPS(Rs)
3.00
2.50
2.50
2.50
2.50
Book NAV/Share(Rs)
286.92
237.08
199.36
159.96
124.50
Tax Rate(%)
24.31
23.53
25.27
24.86
26.28
Margin Ratios
Core EBITDA Margin(%)
10.29
9.86
22.86
22.76
22.85
EBIT Margin(%)
8.60
8.36
20.10
20.69
21.49
Pre Tax Margin(%)
7.95
7.70
19.62
20.25
19.65
PAT Margin (%)
6.02
5.89
14.67
15.22
14.49
Cash Profit Margin (%)
8.07
7.56
18.05
18.05
17.30
Performance Ratios
ROA(%)
10.34
10.00
13.07
14.44
14.13
ROE(%)
18.53
18.47
22.99
27.57
32.51
ROCE(%)
18.80
17.97
22.72
24.92
27.35
Asset Turnover(x)
1.72
1.70
0.89
0.95
0.98
Sales/Fixed Asset(x)
4.12
4.36
2.44
2.96
2.79
Working Capital/Sales(x)
9.40
12.11
4.70
5.80
5.69
Efficiency Ratios
Fixed Capital/Sales(x)
0.24
0.23
0.41
0.34
0.36
Receivable days
29.85
29.56
64.66
89.16
106.53
Inventory Days
57.72
59.64
112.70
101.43
100.27
Payable days
52.98
58.56
67.77
75.73
81.50
Valuation Parameters
PER(x)
8.55
19.47
13.47
17.19
21.53
PCE(x)
6.35
15.20
10.96
14.52
18.06
Price/Book(x)
1.44
3.32
2.80
4.22
5.98
Yield(%)
0.73
0.32
0.45
0.37
0.34
EV/Net Sales(x)
1.17
2.61
2.20
2.84
3.47
EV/Core EBITDA(x)
5.32
12.43
9.33
11.95
14.10
EV/EBIT(x)
6.63
15.24
10.90
13.58
15.95
EV/CE(x)
0.94
1.94
1.73
2.64
3.04
M Cap / Sales
1.05
2.35
1.98
2.65
3.16
Growth Ratio
Net Sales Growth(%)
18.07
18.83
10.42
8.08
13.81
Core EBITDA Growth(%)
23.10
6.03
9.11
4.67
27.50
EBIT Growth(%)
21.25
1.07
6.19
4.10
28.86
PAT Growth(%)
20.45
-2.40
5.38
13.55
28.70
EPS Growth(%)
19.72
-2.41
5.28
13.52
-35.87
Financial Stability Ratios
Total Debt/Equity(x)
0.33
0.50
0.41
0.36
0.69
Current Ratio(x)
1.44
1.28
1.41
1.39
1.31
Quick Ratio(x)
0.77
0.67
0.73
0.74
0.80
Interest Cover(x)
13.32
12.76
42.66
46.80
11.69
Total Debt/Mcap(x)
0.23
0.15
0.15
0.09
0.12